about
Direct analysis of thymic function in children with Down's syndromeNatural Compounds Modulating Mitochondrial FunctionsInhibition of Lon protease by triterpenoids alters mitochondria and is associated to cell death in human cancer cells.Subject classification obtained by cluster analysis and principal component analysis applied to flow cytometric data.Characterization of cells with different mitochondrial membrane potential during apoptosis.Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine.Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic flow cytometry.Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometry.Mitochondria hyperfusion and elevated autophagic activity are key mechanisms for cellular bioenergetic preservation in centenarians.Identification of the Pseudomonas stutzeri OX1 toluene-o-xylene monooxygenase regulatory gene (touR) and of its cognate promoter.Persistent inflammation in HIV infection: established concepts, new perspectives.Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer.T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.Decreased apoptosis of bone marrow progenitor cells in HIV-1-infected patients during highly active antiretroviral therapy.Immunological advantages of everolimus versus cyclosporin A in liver-transplanted recipients, as revealed by polychromatic flow cytometry.Quality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey.Reliable and accurate CD4+ T cell count and percent by the portable flow cytometer CyFlow MiniPOC and "CD4 Easy Count Kit-Dry", as revealed by the comparison with the gold standard dual platform technology.Quercetin and cancer chemopreventionDevelopment of real time PCR assays for the quantification of Fas and FasL mRNA levels in lymphocytes: studies on centenarians.Hepatoma HepG2 cells as a model for in vitro studies on mitochondrial toxicity of antiviral drugs: which correlation with the patient?Anti-HIV drugs and the mitochondria.T cell homeostasis in centenarians: from the thymus to the periphery.Viral strategies for the evasion of immunogenic cell death.Mitochondrial liaisons of p53.Cytometry, immunology, and HIV infection: three decades of strong interactions.Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV.Different origin of adipogenic stem cells influences the response to antiretroviral drugs.Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells.Sirtuin 3 interacts with Lon protease and regulates its acetylation status.Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study.The protease inhibitor atazanavir triggers autophagy and mitophagy in human preadipocytes.Drosophila Helical factor is an inducible protein acting as an immune-regulated cytokine in S2 cells.Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals.Functional characterization of the promoter of the human Lon protease gene.Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease.Morphologic, histochemical, and functional analysis of platelet-rich plasma activity on skeletal cultured cells.Resistance of mtDNA-depleted cells to apoptosis.Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin.The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans.Different sensitivity to apoptosis in cells of monocytic or lymphocytic origin chronically infected with human immunodeficiency virus type-1.
P50
Q24800109-7DA2B5A4-3B20-4DA5-A570-6C29FCFF9631Q28087261-AF39AA95-734B-4C0C-B906-B504CA65F41BQ30393445-8E9555BD-3EDB-4EBA-A5B1-76E08667F720Q31105166-8A8F8AEF-84C2-4C3E-944F-E150F4D41765Q33223961-9F5301A1-7CD4-47C4-A653-8366F256A06AQ33236131-FA1B544D-82F6-4DAB-8AB5-527AD6D3DE75Q33305815-A0E8CEDF-5456-44BB-A102-7A47B6B46D76Q33518424-D7AAC106-7E7F-45D5-B723-1AFCA9E21106Q33657322-320FCF5D-5279-40BF-A66A-746A339CC121Q34012111-BCB5C334-C0BA-4D5C-9680-F1A567FEB7DBQ34401508-56325A3F-0CFD-4C48-81B4-573A69449EC3Q34493828-F9953323-0EFC-4E51-A929-08A9B0D8B8CDQ34510458-DB9BC1A2-2148-4484-8B08-136E3CE583A1Q34550759-FD234EA0-69B6-418C-BC1B-02BD5BB9F6B1Q34635688-A7E243CD-F9B8-45FF-B3C3-C6A5D08C498BQ34785931-CE103EB8-B7F3-4F26-8583-436D15D6D705Q35013375-38AB9F8C-923E-424D-906B-E3ADEEBB87B4Q35106541-E8AD6B27-A40D-4D52-8B50-2D5E6F5D211EQ35114556-2F34E97D-C0F5-4597-B1CB-7FC392A07094Q35547197-2B9FD449-8FB3-45E8-9EC7-C085E08DEC2BQ36510285-EC84CD51-8811-4FB6-97AE-B419EED600EDQ37730121-652AA2D9-B5FB-493E-BA69-83D8EF7C2F73Q37740184-56CBB65C-50CB-4F60-A737-37C1C1AB5F79Q37780205-0D715AED-4B81-423E-8078-3CC49BC12BBBQ38115992-A68AD75C-D211-48CD-8B44-E82CF584A42CQ38226374-5807522E-C013-4D4D-8171-04F8DE7C426CQ38559976-CEBF7A1A-97B6-4FE4-992E-4CDFAA5B68ACQ38963045-E33D2FA8-841F-4CBD-B427-51BBAF3EEE54Q38965419-06646301-CDEE-459D-8762-21B607F278EEQ39284121-D7FF3507-C224-4ACB-A5D6-325C964F841CQ39285583-B5D679C0-09CC-4073-A67F-4E77819ECA71Q39386618-6DD0CD18-ECBF-433A-B907-AD4077972391Q39530488-426AABCA-2E3B-4B0E-A36E-CF289A7E9BB4Q39646512-FA135B59-7760-4C5D-9CBA-8372B08D3ADFQ39737637-506086C9-007C-466F-9BB8-CD94BFA1FFB5Q39857249-0BA7EE59-F308-4988-BFC6-61B929F01748Q40008780-1F8FA025-9511-4102-9713-8DF8F11F9350Q40349362-AF6A9B0C-4EDD-4574-BC05-EAA1F5FE9918Q40516231-B1366F5C-0DC8-4308-BCA8-D1181008937BQ40606341-F8AA5153-6DA8-4FBF-9628-273B40D07839
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marcello Pinti
@ast
Marcello Pinti
@en
Marcello Pinti
@es
Marcello Pinti
@sl
type
label
Marcello Pinti
@ast
Marcello Pinti
@en
Marcello Pinti
@es
Marcello Pinti
@sl
prefLabel
Marcello Pinti
@ast
Marcello Pinti
@en
Marcello Pinti
@es
Marcello Pinti
@sl
P1053
C-9351-2015
P106
P1153
6701578776
P21
P31
P3829
P496
0000-0001-9118-1262